# OnCo record cinacalcet (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cinacalcet/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cinacalcet" ;
  schema:name "Cinacalcet"@en ;
  schema:description "Cinacalcet is a tablet that quiets overactive parathyroid tissue, approved in 2004 and labelled for the dangerous high calcium levels of parathyroid carcinoma, a rare cancer where surgery often cannot remove all the hormone-producing tissue."@en ;
  schema:url <https://onco.cc/drugs/cinacalcet/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cinacalcet> ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021688>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=cinacalcet>, <https://en.wikipedia.org/wiki/Cinacalcet> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Oral small-molecule calcimimetic" ;
  schema:alternateName "Sensipar / Mimpara" ;
  onco:approval "US 2004: Hypercalcaemia in patients with parathyroid carcinoma; secondary hyperparathyroidism on dialysis; primary hyperparathyroidism when surgery is not possible" ;
  onco:cancers <https://onco.cc/cancers/parathyroid-carcinoma/> ;
  onco:companies <https://onco.cc/companies/amgen/> ;
  onco:trials <https://onco.cc/trials/nct01054079/> .
